BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23406965)

  • 1. High-risk human papillomavirus infection in HIV-positive African women living in Europe.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Int AIDS Soc; 2013 Feb; 16(1):18023. PubMed ID: 23406965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; De Marchin J; Feoli F; Delforge M; Clumeck N; De Wit S
    AIDS; 2016 Jan; 30(3):425-33. PubMed ID: 26765936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
    BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
    Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest of cytology combined with Xpert
    Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
    HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
    J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
    Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
    Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical, anal and oral human papillomavirus (HPV) infection in young women: A case control study between women with perinatally HIV infection and women with non-perinatally HIV infection.
    Gilles C; Buljubasic M; Konopnicki D; Manigart Y; Barlow P; Rozenberg S
    Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():114-119. PubMed ID: 31785467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women.
    Ezechi OC; Ostergren PO; Nwaokorie FO; Ujah IA; Odberg Pettersson K
    Virol J; 2014 Jan; 11():5. PubMed ID: 24433568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia.
    Katundu K; Bateman AC; Pfaendler KS; Mwanahamuntu MH; Kapambwe S; Vermund SH; Sahasrabuddhe VV; Msadabwe SC; Stringer JS; Parham GP; Chibwesha CJ
    J Low Genit Tract Dis; 2015 Oct; 19(4):301-6. PubMed ID: 26125097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.
    Hanisch RA; Sow PS; Toure M; Dem A; Dembele B; Toure P; Winer RL; Hughes JP; Gottlieb GS; Feng Q; Kiviat NB; Hawes SE;
    J Clin Virol; 2013 Dec; 58(4):696-702. PubMed ID: 24210330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
    Shrestha S; Sudenga SL; Smith JS; Bachmann LH; Wilson CM; Kempf MC
    BMC Infect Dis; 2010 Oct; 10():295. PubMed ID: 20946655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
    Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC
    Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV associated high-risk HPV infection among Nigerian women.
    Akarolo-Anthony SN; Al-Mujtaba M; Famooto AO; Dareng EO; Olaniyan OB; Offiong R; Wheeler CM; Adebamowo CA
    BMC Infect Dis; 2013 Nov; 13():521. PubMed ID: 24192311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomaviruses distribution in Romanian women with negative cytology.
    Plesa A; Socolov D; Huica I; Botezatu A; Iancu IV; Ungureanu C; Teleman S; Albulescu A; Fudulu A; Anton G
    J Infect Dev Ctries; 2019 Apr; 13(4):326-333. PubMed ID: 32045377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India.
    Menezes LJ; Poongulali S; Tommasino M; Lin HY; Kumarasamy N; Fisher KJ; Saravanan S; Gheit T; Ezhilarasi C; Jeeva A; Lu B; Giuliano AR
    Int J STD AIDS; 2016 Jun; 27(7):543-53. PubMed ID: 26002318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.